185 related articles for article (PubMed ID: 25257978)
21. QuitNic: A Pilot Randomized Controlled Trial Comparing Nicotine Vaping Products With Nicotine Replacement Therapy for Smoking Cessation Following Residential Detoxification.
Bonevski B; Manning V; Wynne O; Gartner C; Borland R; Baker AL; Segan CJ; Skelton E; Moore L; Bathish R; Chiu S; Guillaumier A; Lubman DI
Nicotine Tob Res; 2021 Feb; 23(3):462-470. PubMed ID: 32770246
[TBL] [Abstract][Full Text] [Related]
22. A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.
Haggsträm FM; Chatkin JM; Sussenbach-Vaz E; Cesari DH; Fam CF; Fritscher CC
Pulm Pharmacol Ther; 2006; 19(3):205-9. PubMed ID: 16517193
[TBL] [Abstract][Full Text] [Related]
23. Pre-quit depression level and smoking expectancies for mood management predict the nature of smoking withdrawal symptoms in college women smokers.
Copeland AL; Kulesza M; Hecht GS
Addict Behav; 2009 May; 34(5):481-3. PubMed ID: 19157715
[TBL] [Abstract][Full Text] [Related]
24. A Randomized Clinical Trial of Nicotine Preloading for Smoking Cessation in People with Posttraumatic Stress Disorder.
Dedert EA; Dennis PA; Calhoun PS; Dennis MF; Beckham JC
J Dual Diagn; 2018; 14(3):148-157. PubMed ID: 29693495
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.
Hendricks PS; Delucchi KL; Hall SM
Drug Alcohol Depend; 2010 Jun; 109(1-3):114-9. PubMed ID: 20096510
[TBL] [Abstract][Full Text] [Related]
26. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
27. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.
Hall SM; Reus VI; Muñoz RF; Sees KL; Humfleet G; Hartz DT; Frederick S; Triffleman E
Arch Gen Psychiatry; 1998 Aug; 55(8):683-90. PubMed ID: 9707377
[TBL] [Abstract][Full Text] [Related]
28. Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease.
Thorndike AN; Regan S; McKool K; Pasternak RC; Swartz S; Torres-Finnerty N; Rigotti NA
Arch Intern Med; 2008 Jan; 168(2):186-91. PubMed ID: 18227366
[TBL] [Abstract][Full Text] [Related]
29. Do Psychiatric Disorders or Measures of Distress Moderate Response to Postpartum Relapse Prevention Interventions?
Kolko RP; Emery RL; Cheng Y; Levine MD
Nicotine Tob Res; 2017 May; 19(5):615-622. PubMed ID: 28403471
[TBL] [Abstract][Full Text] [Related]
30. Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.
Piasecki TM; Jorenby DE; Smith SS; Fiore MC; Baker TB
Exp Clin Psychopharmacol; 2003 Nov; 11(4):276-85. PubMed ID: 14599261
[TBL] [Abstract][Full Text] [Related]
31. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
32. A comparison of sustained-release bupropion and placebo for smoking cessation.
Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
[TBL] [Abstract][Full Text] [Related]
33. Can brain games help smokers quit?: Results of a randomized clinical trial.
Loughead J; Falcone M; Wileyto EP; Albelda B; Audrain-McGovern J; Cao W; Kurtz MM; Gur RC; Lerman C
Drug Alcohol Depend; 2016 Nov; 168():112-118. PubMed ID: 27635998
[TBL] [Abstract][Full Text] [Related]
34. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.
Catley D; Harris KJ; Okuyemi KS; Mayo MS; Pankey E; Ahluwalia JS
Nicotine Tob Res; 2005 Dec; 7(6):859-70. PubMed ID: 16298721
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
[TBL] [Abstract][Full Text] [Related]
36. Mediating mechanisms for the impact of bupropion in smoking cessation treatment.
Lerman C; Roth D; Kaufmann V; Audrain J; Hawk L; Liu A; Niaura R; Epstein L
Drug Alcohol Depend; 2002 Jul; 67(2):219-23. PubMed ID: 12095672
[TBL] [Abstract][Full Text] [Related]
37. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
Anthenelli RM; Blom TJ; McElroy SL; Keck PE
Addiction; 2008 Apr; 103(4):687-94. PubMed ID: 18339115
[TBL] [Abstract][Full Text] [Related]
38. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.
Dunn KE; Marcus TF; Kim C; Schroeder JR; Vandrey R; Umbricht A
Nicotine Tob Res; 2016 May; 18(5):1171-9. PubMed ID: 26476459
[TBL] [Abstract][Full Text] [Related]
39. Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.
Zuo Y; Rabinovich NE; Gilbert DG
Psychopharmacology (Berl); 2017 Mar; 234(5):761-771. PubMed ID: 28028602
[TBL] [Abstract][Full Text] [Related]
40. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Gonzales D; Jorenby DE; Brandon TH; Arteaga C; Lee TC
Addiction; 2010 Nov; 105(11):2002-13. PubMed ID: 20819082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
